Sponsor study identifier
interventional
4
1 country
1
Study Start
January 1, 2018
Actual (reported)Primary Completion
January 1, 2019
Actual (reported)Study Completion
January 1, 2019
Actual (reported)Introduction: A rectovaginal fistula (RVF) is an epithelium-lined abnormal tract between the rectum and the vagina and is often a challenging problem for both the patients and to the surgeons. In literature, there is still debate regarding the best treatment options for rectovaginal fistulas. Aim: To assess the results of the treatment of rectovaginal fistulas with incontinence and impaired anal tonus using fistulectomy, sphincteroplasty with or without bulbocavernosus muscle (Martius) flap. Materials and Methods: A total of 22 consecutive patients with simple RVFs were included and assigned to transperineal repair. The patients were divided into two groups , group1: with Martius flap; group2: without Martius flap .Postoperatively, patients were followed up for one year at the outpatient clinic or through telephone interviews with specific questionnaires to collect information on the status of fecal control, flatus, or fecal leakage from the vagina.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
January 1, 2019
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 1, 2018
Actual (reported)January 1, 2019
Actual (reported)January 1, 2019
Actual (reported)February 9, 2020
Actual (reported)February 13, 2020
Actual (reported)rectovaginal fistula repair with or without Martius flap
detect recurrence in rectovaginal fistula repair with or without Martius flap
1 year
RVF with Martius flap
RVF without Martius flap
rectovaginal fistula repair with Martius flap
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Tamer Alsaied Alnaimy
Zagazig, Sharqia Province, 055, Egypt
tamer A. alnaimy, MD
Zagazig University
4 participants (actual enrollment reported by the registry).
First Submitted
February 9, 2020
First Posted
February 13, 2020
Study Start
January 1, 2018
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
January 1, 2019
Actual (reported)Study Completion
January 1, 2019
Actual (reported)Last Updated
February 13, 2020
Record last verified: 2020-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: